Skip to main content

Table 1 Patient and SPL characteristics and outcomes of EUS-FNAB

From: Efficacy of EUS-guided FNB using a Franseen needle for tissue acquisition and microsatellite instability evaluation in unresectable pancreatic lesions

  FNB (N = 28) FNA (N = 61) P value
Age, y, median (range) 68 (49–91) 70 (38–85) 0.33
Sex, male/female 18/10 30/31 0.25
Final diagnosis    0.09
 Pancreatic cancer 28 54  
 Pancreatic neuroendocrine tumor   7  
SPL size, mm, median (range) 25 (15–50) 27 (7–82) 0.81
SPL location, head/body or tail 11/17 27/34 0.82
Lesion resectability, R/UR 6/22 25/36 0.09
Puncture route, gastric/duodenal 20/8 42/29 1.0
Puncture number, median (range) 3 (2–5) 4 (1–8) < 0.01
Histological specimen, n (%) 26 (92.9) 42 (68.9) 0.015
Adverse events, n (%) 0 (0) 2 (3.3) 1.0
 Acute pancreatitis, n   1  
 Bleeding, n   1  
  1. SPL Solid pancreatic lesion, R Resectable, UR Unresectable
\